Montpellier, Bulgaria

Lubomir Vezenkov

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Universitè De Montpellier. Active years: 2015.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: An Insight into Inventor Lubomir Vezenkov

Introduction: Lubomir Vezenkov, a prominent inventor based in Montpellier, Bulgaria, is known for his innovative contributions to the field of vectorization agents. With a focus on the use of constrained peptide mimic oligomers, Vezenkov has made significant strides in the realm of active ingredient delivery.

Latest Patents: Lubomir Vezenkov holds one notable patent titled "Use of constrained peptide mimic oligomers as vectorization agents." This invention focuses on the application of oligomers with constrained dipeptide or tripeptide motifs as effective agents for the vectorization of active ingredients, showcasing his expertise in biochemistry and materials science.

Career Highlights: Throughout his career, Vezenkov has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and Université de Montpellier. His work at these renowned research organizations has provided him with a robust foundation in scientific research and innovation.

Collaborations: Lubomir has collaborated with talented individuals such as Muriel Amblard and Jean Martinez. These partnerships have contributed to the advancement of his research, further solidifying his reputation in the scientific community.

Conclusion: With a keen focus on the development of novel vectorization agents, Lubomir Vezenkov's contributions are notable within the field of innovation. His patent serves as a testament to his innovative spirit and dedication to improving the delivery of active ingredients, marking him as an influential inventor in the domain of biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…